Ignite Creation Date:
2025-12-24 @ 5:17 PM
Ignite Modification Date:
2026-01-12 @ 11:08 PM
Study NCT ID:
NCT04797650
Status:
COMPLETED
Last Update Posted:
2023-07-03
First Post:
2021-03-10
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study to Evaluate the Efficacy and Safety of CTP-543 in Adults With Moderate to Severe Alopecia Areata (THRIVE-AA2)
Sponsor:
Concert Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-06-10
Start Date Type:
ACTUAL
Primary Completion Date:
2022-06-08
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-06-29
Completion Date Type:
ACTUAL
First Submit Date:
2021-03-10
First Submit QC Date:
None
Study First Post Date:
2021-03-15
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2023-06-05
Results First Submit QC Date:
None
Results First Post Date:
2023-07-03
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-06-30
Last Update Post Date:
2023-07-03
Last Update Post Date Type:
ACTUAL